Clarivate (CLVT)
(Delayed Data from NYSE)
$6.83 USD
+0.06 (0.89%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $6.83 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.83 USD
+0.06 (0.89%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $6.83 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Zacks News
Sabre (SABR) Plunges 19% on Wider-Than-Expected Q4 Loss
by Zacks Equity Research
Sabre's (SABR) lower-than-expected Q4 top-line performance raises concerns for the slow post-pandemic recovery of the travel technology company.
Sabre (SABR) Renews Multi-Year Deal With JetBlue Airways
by Zacks Equity Research
The latest renewed multi-year agreement with JetBlue Airways depicts the growing trust in Sabre's (SABR) PSS and GDS solutions by leading air carriers.
Clarivate PLC (CLVT) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Clarivate PLC (CLVT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CyberArk (CYBR) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
CyberArk's (CYBR) fourth-quarter 2022 results reflect the strong demand for the company's SaaS solutions and on-premise subscription offerings.
New Strong Buy Stocks for February 10th
by Zacks Equity Research
SNEX, DTEGY, CLVT, HAE and ARCC have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2022.
Sangoma Technologies Corporation (SANG) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Sangoma Technologies Corporation (SANG) delivered earnings and revenue surprises of 0% and 7.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Paycom (PAYC) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Paycom's (PAYC) Q4 results reflect the benefits of strong demand, new business wins and the adoption of recent new product offerings.
NCR Corporation (NCR) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
NCR Corporation's (NCR) Q4 results reflect strong execution, solid growth across business segments, increased pricing and cost-saving actions.
Fortinet (FTNT) Soars 13% on Q4 Earnings Beat, Strong Guidance
by Zacks Equity Research
The strong demand for Core and Enhanced Platform Technologies aids Fortinet's (FTNT) Q4 top line, while an improved supply chain, positive pricing actions and discounting policies in the Product segment drive earnings higher.
Is Clarivate (CLVT) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Clarivate PLC (CLVT) and Lyft (LYFT) have performed compared to their sector so far this year.
Gen Digital (GEN) Tops on Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Gen Digital's (GEN) Q3 results reflect strong customer growth and the benefits of the global business expansion and the Avast acquisition, leading to year-over-year growth in revenues and bookings.
Paylocity (PCTY) Soars 4% on Q2 Earnings Beat, Guidance Raise
by Zacks Equity Research
Better sales execution and sustained investments in technological upgrades and product innovation drive Paylocity's (PCTY) Q2 earnings and revenues higher.
Time to Buy these Top-Rated Growth Stocks at a Discount?
by Shaun Pruitt
These three stocks have seen stellar EPS growth over the last five years and their attractive valuations make them appear to have more short-term upside in addition to being solid long-term investments.
Zacks.com featured highlights include Clarivate, Expedia Group and Haemonetics
by Zacks Equity Research
Clarivate, Expedia Group and Haemonetics are part of the Zacks Screen of the Week article.
Time To Pick These 3 Top Relative Price Strength Stocks
by Nilanjan Choudhury
Clarivate Plc (CLVT), Expedia Group (EXPE) and Haemonetics Corporation (HAE) are three stocks with explosive relative price strength.
The Zacks Analyst Blog Highlights AMN Healthcare Services, Clarivate, Core & Main, CRH and Deere & Co.
by Zacks Equity Research
AMN Healthcare Services, Clarivate, Core & Main, CRH and Deere & Co. are part of the Zacks top analyst blog.
Wall Street Books Best Week Since November: 5 Growth Picks
by Tirthankar Chakraborty
The stock market gains momentum as consumer sentiment improves on fading inflation. Thus, invest in growth players like AMN Healthcare Services (AMN), Clarivate (CLVT), Core & Main (CNM), CRH & Deere (DE) for solid returns.
How Much Upside is Left in Clarivate PLC (CLVT)? Wall Street Analysts Think 39.2%
by Zacks Equity Research
The mean of analysts' price targets for Clarivate PLC (CLVT) points to a 39.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Is the Options Market Predicting a Spike in Clarivate (CLVT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Clarivate (CLVT) stock based on the movements in the options market lately.
Clarivate PLC (CLVT) Q3 Earnings Beat Estimates
by Zacks Equity Research
Clarivate PLC (CLVT) delivered earnings and revenue surprises of 17.65% and 1.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Vishay Intertechnology (VSH) Q3 Earnings Beat Estimates
by Zacks Equity Research
Vishay (VSH) delivered earnings and revenue surprises of 9.41% and 0.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Clarivate PLC (CLVT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Clarivate PLC (CLVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Clarivate (CLVT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Clarivate (CLVT) stock based on the movements in the options market lately.
Clarivate PLC (CLVT) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Clarivate PLC (CLVT) delivered earnings and revenue surprises of 4.76% and 0.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Covetrus (CVET) Q2 Earnings Match Estimates
by Zacks Equity Research
Covetrus (CVET) delivered earnings and revenue surprises of 0% and 1.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?